Assessing epidemic curves for evidence of superspreading.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

4 citing papers in PubMed.

1. Unjustified Poisson assumptions lead to overconfident estimates of the effective reproductive number.Epidemiology and infection · 2026
   Article
2. Accuracy of Inferences About the Reproductive Number and Superspreading Potential of SARS-CoV-2 with Incomplete Contact Tracing Data.Research square · 2023
   Article
3. Hybrid prediction of infections and deaths due to COVID-19 in two Colombian data series.PloS one · 2023
   Article
4. Assessing epidemic curves for evidence of superspreading.Journal of the Royal Statistical Society. Series A, (Statistics in Society) · 2022
   Article

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

Authors and funding

2 authors.

Funding

No grant is acknowledged in the PubMed record.

Abstract

Indexed as